Navigation Links
Novel Technology Breaks Through Cancer Pain
Date:8/19/2007

kly into the bloodstream. Instead of requiring removal upon completion of the drug delivery, the BEMA disc disintegrates in the mouth and leaves no drug residue.

The results of the Phase III pivotal efficacy clinical trial in cancer patients with breakthrough pain announced earlier this year with BEMA Fentanyl are very encouraging.

"The results of our study demonstrated that fentanyl could be delivered rapidly, effectively and easily using the BEMA technology," said Finn. "Besides allowing greater absorption of fentanyl, the BEMA disc was easier to use, as it only required seconds to apply."

It is estimated that at least 60 percent of people with advanced cancer will experience significant pain of some type, oftentimes including breakthrough pain. For more information on BEMA Fentanyl, log on to http://www.bdsinternational.com/


'/>"/>
SOURCE BioDelivery Sciences

Copyright©2007 PR Newswire.

Page: 1 2

Related medicine technology :

1. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
2. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
3. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
4. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
5. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
6. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
7. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
8. Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory Compound, Shows Efficacy in Psoriasis
9. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
10. Encouraging Clinical Activity of GSKs Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer
11. Clinical Data on ARIADs Novel mTOR Inhibitor, AP23573, To Be Presented at the ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)...  Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its ... 2014 Clinical Lab Expo today by unveiling two booths ... is partnering with customers to redefine the value of ... day that they,re looking for a partner to help ... and offices," said Jack Phillips , president and ...
(Date:7/29/2014)... DUBLIN , July 29, 2014 ... the "Global Respiratory Devices Market 2014-2018" report ... A respiratory device is a medical ... who is having difficulty in breathing and cannot achieve ... disorders such as cystic fibrosis, asthma, COPD, and ARDS ...
(Date:7/29/2014)... Medical Corporation (Apex, TWSE: 4106), a leading player in the ... is appealing the judgment of the Regional Court of ... that found the headgear of certain mask models infringe a ... against various ResMed patents in major countries. Apex further reiterates ... ResMed filed the lawsuit with the Regional ...
Breaking Medicine Technology:Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4Global Respiratory Devices Market 2014-2018 2Apex Continues Fighting Against Patents to Free Up Competition 2
... -- China Medical Technologies, Inc. (the "Company") (Nasdaq: ... ("IVD") company, today announced that its subsidiary, Beijing GP ... sixth in the Deloitte Technology Fast 50 China 2010 ... molecular diagnostic businesses of the Company. The ...
... Oct. 21 Investigators from Texas Children,s Hospital ... North America came together in Houston to analyze ... the Berlin Heart EXCOR® Pediatric Ventricular Assist Device ... more about the study, see: http://bit.ly/bfrA1J ...
Cached Medicine Technology:China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program 2Texas Children's Hospital Hosts North American Investigators on Berlin Heart Trial 2Texas Children's Hospital Hosts North American Investigators on Berlin Heart Trial 3Texas Children's Hospital Hosts North American Investigators on Berlin Heart Trial 4
(Date:7/29/2014)... 29, 2014 (HealthDay News) -- Although the bite of ... heal well if left alone, an expert notes. ... an adverse reaction to a brown recluse spider bite, ... Poison Center, particularly since these potentially dangerous bites are ... for us to do nothing. The [bite] has classic ...
(Date:7/29/2014)... CarePoint Health is proud to ... network, CarePoint Health Medical Group. Our system welcomes ... of highly skilled and experienced physicians comprise CarePoint ... doctors and practices in Hudson County, representing a ... CarePoint Health’s commitment to provide the highest quality ...
(Date:7/29/2014)... Alan Mozes HealthDay Reporter ... autism patients with just a single dose of the hormone ... emotions, Japanese researchers report. Known as the "love hormone," ... bonding between lovers, and between mothers and their children. ... key area of the brain that has long been associated ...
(Date:7/29/2014)... Summer is here, and that means it’s time to ... in a pool or laying out on the beach. However, warm ... Puppy Store is here to help pet owners protect their dogs ... impossible to completely keep fleas and ticks at bay, but there ... their pets coming into contact with fleas and ticks. , Flea ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Bret ... LLP ’s Boise office, has been appointed to the ... Greater Idaho. , Busacker is an experienced business attorney ... matters. He advises clients on a wide spectrum of ... plan administration, compliance, and governance concerns. His clients include ...
Breaking Medicine News(10 mins):Health News:Brown Recluse Spider Bites on the Rise, Expert Warns 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 2Health News:Dr. Politis and Dr. Kaki Join CarePoint Health Medical Group 3Health News:'Love Hormone' Oxytocin May Help Some With Autism 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 3Health News:Protect Dogs From Fleas and Ticks During the Summer 2Health News:Holland & Hart Partner Brett Busacker Appointed to Board of Directors for American Red Cross of Greater Idaho 2
... monensin emerged in a project investigating the effects of ... prostate cancer cells. The project involved most of the ... amounts of compounds disulfiram (Antabus), thiram, tricostatin A, ... cancer cells without significant effects on the growth of ...
... , SATURDAY, Dec. 18 (HealthDay News) -- The hectic pace ... with chronic pain or other persistent health conditions to maintain ... risk for missed doses and even medication errors, according to ... can ensure safe and effective medication use over the holidays, ...
... future of cancer treatment and a University of Alberta graduate ... competitors from 80 of the best university graduate schools in ... of a light-sensitive drug to treat prostate cancer. ... research reviewed internally at the U of A and was ...
... Dec. 17 (HealthDay News) -- Among people with rheumatoid arthritis, ... is, even if they had been seeing one for quite ... people surveyed couldn,t decipher other medical words related to rheumatoid ... who conducted the survey noted that previous findings have suggested ...
... (HealthDay News) -- Differences in immune signaling pathways among ... than other primates to certain infectious diseases, researchers say. ... of HIV to AIDS or severe complications from hepatitis ... sensitive than chimpanzees to the serious effects of these ...
... perfect. It can indicate cancer when none is present and ... is more reliable in men taking dutasteride (Avodart), a drug ... lowers PSA levels by about half within six months. But ... levels among men taking the drug was a stronger indicator ...
Cached Medicine News:Health News:Finnish researchers find a compound that prevents the growth of prostate cancer cells 2Health News:Hectic Holiday Pace Can Upset Medication Schedule 2Health News:Master's student takes top thesis competition while tackling prostate cancer research 2Health News:Patient Literacy Problems Can Hinder Rheumatoid Arthritis Care 2Health News:Primate Immune System Differences Identified 2Health News:PSA test better predicts cancer in men taking prostate-shrinking drug 2Health News:PSA test better predicts cancer in men taking prostate-shrinking drug 3
The airlock allows anaerobic entry of large flasks, vessels, and up to 90 plates at a time....
Lose the variability of anaerobic jars and step into the 21st century with the anaerobic workstation that provides the answer to the common problems associated with anaerobic microbiology....
The 500 plate capacity MG-500 has an airlock for ease of use and an additional 100 plate capacity. Refrigeration is also available for growth of psychrophilic organisms...
... SATURN is adjustable in all directions by ... due to its simple, flexible handling. Alternatively, ... wired remote control or the operating panel ... and the seat section extension provide excellent ...
Medicine Products: